powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1790136182
Emily Brugioni
DO
Hematology-Oncology
Des Moines,
IA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
91.8
Quality
91.1
Cost
81.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.71%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$146
Payment records
2
By payment type
Education
$99
Food and Beverage
$47
Top paying entities
Education
$99
Food and Beverage
$47
PRESCRIBING · PART D · 2024
Total Rx claims
1,210
Beneficiaries
—
Total drug cost
$1.8M
Distinct drugs
34
Brand share
17.4%
Top prescribed drugs
Anastrozole
166 claims
Acyclovir
106 claims
Prednisone
81 claims
Apixaban
60 claims
Ondansetron Hcl
57 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,998
Unique beneficiaries
—
Total services
19,482
Distinct HCPCS
32
Medicare payment
$191K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 50 Hematology-Oncology providers in IA — above median (cohort median 1,234).
